Literature DB >> 17255778

Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: A new proposal for the substaging of pT3a prostate cancer.

Ming-Tse Sung1, Haiqun Lin, Michael O Koch, Darrell D Davidson, Liang Cheng.   

Abstract

Extraprostatic extension is an unfavorable prognostic factor for prostate cancer. Consequently, it has been assigned to pT3a in the current 2002 tumor, lymph node, metastasis staging system. The aim of our study is to analyze the extent of extraprostatic extension by 8 quantitative methods and to determine which is best for substaging of pT3a tumors. We studied 83 patients with extraprostatic extension after radical prostatectomy for clinically localized prostatic adenocarcinoma. The extent of extraprostatic extension was evaluated using 8 quantitative methods. Univariate and multivariate analyses were performed to determine which measurement best predicts prostate-specific antigen (PSA) recurrence. In the univariate analysis, the radial distance of extraprostatic tumor measured by ocular micrometer was associated with PSA recurrence (P = 0.02). No significant association was observed between PSA recurrence and other measurements of extraprostatic extension, including focal versus established extraprostatic extension using Epstein's criterion, focal versus established extraprostatic extension using Wheeler's modified criterion, the number of extraprostatic neoplastic glands, unilateral versus bilateral involvement, circumferential length of extraprostatic tumor, unifocal versus multifocal involvement, and volume of extraprostatic tumor. In the multivariate analysis, radial distance remained an independent predictor of PSA recurrence (hazard ratio, 2.4; 95% confidence interval, 1.12-5.01; P=0.02). The radial distance of the extraprostatic extension measured by ocular micrometer is an independent prognostic factor for pT3 prostate cancer. Two-year and 4-year PSA recurrence-free survival was 62% and 35%, respectively, for those patients with radial distance <0.75 mm, as compared with 35% and 18%, respectively, for those with radial distance > or =0.75 mm. We recommend reporting this parameter routinely for radical prostatectomy specimens. The strength of its prognostic value for PSA recurrence makes it a potential criterion for incorporation into a future tumor, lymph node, metastasis staging system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255778     DOI: 10.1097/01.pas.0000213359.26003.37

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  11 in total

Review 1.  [Diagnostics of radical prostatectomy specimens. Results of the 2009 consensus conference of the International Society of Urological Pathology].

Authors:  G Kristiansen; J R Srigley; B Delahunt; L Egevad
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

2.  Impact of the extent of extraprostatic extension defined by Epstein's method in patients with negative surgical margins and negative lymph node invasion.

Authors:  T Maubon; N Branger; C Bastide; G Lonjon; K-A Harvey-Bryan; P Validire; S Giusiano; D Rossi; X Cathelineau; F Rozet
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-12       Impact factor: 5.554

3.  Biospecimen reporting for improved study quality (BRISQ).

Authors:  Helen M Moore; Andrea B Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Daniel F Hayes; Pierre Hainaut; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  J Proteome Res       Date:  2011-06-21       Impact factor: 4.466

4.  A Grading System for Extraprostatic Extension of Prostate Cancer That We Can All Agree Upon?

Authors:  Peter L Choyke
Journal:  Radiol Imaging Cancer       Date:  2020-01-17

5.  Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples.

Authors:  Metka Volavšek; Vanessa Henriques; Ana Blanca; Rodolfo Montironi; Liang Cheng; Maria R Raspollini; Alessia Cimadamore; Nuno Vau; Francesco Pierconti; Antonio Lopez-Beltran
Journal:  Virchows Arch       Date:  2019-10-07       Impact factor: 4.064

Review 6.  Extraprostatic extension in prostate cancer: primer for radiologists.

Authors:  Alice C Shieh; Ezgi Guler; Vijayanadh Ojili; Raj Mohan Paspulati; Robin Elliott; Nikhil H Ramaiya; Sree Harsha Tirumani
Journal:  Abdom Radiol (NY)       Date:  2020-12

7.  Biospecimen Reporting for Improved Study Quality.

Authors:  Helen M Moore; Andrea Kelly; Scott D Jewell; Lisa M McShane; Douglas P Clark; Renata Greenspan; Pierre Hainaut; Daniel F Hayes; Paula Kim; Elizabeth Mansfield; Olga Potapova; Peter Riegman; Yaffa Rubinstein; Edward Seijo; Stella Somiari; Peter Watson; Heinz-Ulrich Weier; Claire Zhu; Jim Vaught
Journal:  Biopreserv Biobank       Date:  2011-04       Impact factor: 2.300

8.  Assessing Extraprostatic Extension with Multiparametric MRI of the Prostate: Mehralivand Extraprostatic Extension Grade or Extraprostatic Extension Likert Scale?

Authors:  Lars A R Reisæter; Ole J Halvorsen; Christian Beisland; Alfred Honoré; Karsten Gravdal; Are Losnegård; Jan Monssen; Lars A Akslen; Martin Biermann
Journal:  Radiol Imaging Cancer       Date:  2020-01-17

9.  HDR Brachytherapy in the Management of High-Risk Prostate Cancer.

Authors:  Susan Masson; Raj Persad; Amit Bahl
Journal:  Adv Urol       Date:  2012-02-22

10.  Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance.

Authors:  Knut Håkon Hole; Karol Axcrona; Agnes Kathrine Lie; Ljiljana Vlatkovic; Oliver Marcel Geier; Bjørn Brennhovd; Kjetil Knutstad; Dag Rune Olsen; Therese Seierstad
Journal:  Eur Radiol       Date:  2012-11-01       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.